Clinical Trial Update: A Study of Clofarabine and Cytarabine for Older Patients With Relapsed or Refractory Acute Myelogenous Leukemia (AML)(CLASSIC I) [Phase 3]

View source ↗

Summary

Phase 3 CLASSIC I trial evaluating clofarabine in combination with cytarabine for older patients with relapsed or refractory acute myeloid leukemia; results hav…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• CYTARABINE (CYTARABINE)
• Clofarabine (clofarabine)

Snippet

Sponsor: Genzyme, a Sanofi Company | Conditions: Acute Myelogenous Leukemia | Phase 3 | Status: COMPLETED | Results posted: 2011-09-15